MedTrace Logo

Validation of Accexible as a Tool for Screening and Monitoring Depression.

NCT06044818 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 166

Last updated 2026-03-25

No results posted yet for this study

Summary

Major depressive disorder (MDD) is a chronic disease with a prevalence around 8-12% and is considered one of the most debilitating disease worldwide.

A recent orientation is the analysis of language in relation to the description of images with a high and varied semantic and emotional content. It can be studied that changes in the description of an image check if these changes are associated with the evolution of a person with probable impairment both in memory and cognitive as well as emotional, psychiatric, behavioral and even in their interaction with environmental factors especially those associated with socialization and loneliness.

The present study has the objective of validating Accexible as a tool for Screening and Monitoring Depression.

Conditions

  • Major Depressive Disorder (MDD)

Interventions

DEVICE

Accexible

Speech Analysis

Sponsors & Collaborators

  • Accexible

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-10
Primary Completion
2025-04-17
Completion
2025-04-17

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06044818 on ClinicalTrials.gov